IDO1 and renal cell carcinoma: While increased IDO1 expression has been associated with worse patient outcomes in a number of human malignancies [36] including esophageal SCC [37, 38], other tumors such as renal cell carcinoma, hepatocellular carcinoma, and melanoma demonstrate a correlation between IDO1 expression and improved survival [39].